Product portfolio jubilant oral solids (IR and NDDS)

Jubilant Pharmaceuticals holds an extensive portfolio of generic dossiers for out-licensing and supplies its customers with the finished medicinal products, manufactured according to c-GMP norms. The following developments in oral solids (IR and NDDS) are available for out-licensing:

 

Product Reference product EU patent expiry date Therapeutic class Registration info
Pantoprazole 20/40 mg Gastro-resistant tablets Zurcale 05/2009 Gastro-intestinal Registration ongoing
 
Donepezil HCl 5/10 mg Filmcoated tablets Aricept 02/2012 CNS: Anti-Alzheimer Registration ongoing
 
Levofloxacin hemihydrate 250/500 mg Filmcoated tablets Tavanic 06/2011 Antibiotics Registration ongoing
 
Quetiapine fumarate 25/100/150/200/300 mg Filmcoated tablets Seroquel 03/2012 CNS: Antipsychotic Registration ongoing
 
Losartan potassium 25/50/100 mg Filmcoated tablets Cozaar 09/2009 Cardiovascular Registration ongoing
 
Losartan potassium + HCTZ 50+12.5/100+25 mg Filmcoated tablets Cozaar-Comp 02/2010 Cardiovascular Registration ongoing
 
Olanzapine 2.5/5/7.5/10/15/20 mg Filmcoated tablets Zyprexa 09/2011 CNS: Antipsychotic DCP in finalisation
 
Irbesartan 75/150/300 mg Filmcoated tablets Aprovel 08/2012 Cardiovascular Registration ongoing
 
Oxcarbazepine 150/300/600 mg Filmcoated tablets Trileptal Expired Anticonvulsant (anti-epileptic) Registration ongoing
 
Olanzapine 5/10/15/20 mg Mouth dissolving tablets Zyprexa 09/2011 CNS: Antipsychotic DCP in finalisation
 
Ropinirole HCl 0.25/0.5/1/2 mg Filmcoated tablets Requip 07/2011 Expired CNS: Anti-Parkinson Registration ongoing
 
Repaglinide 0.5/1/2 mg Tablets Prandin 08/2013 Antidiabetic Registration ongoing
 
Azithromycin dihydrate 250/500 mg Tablets Zithromax Expired Antibacterial DCP slot confirmed
 
Risedronate sodium 5/30/35 mg Filmcoated tablets Actonel 12/2010 Bone calcium regulator DCP slot confirmed
 
Zolmitriptan 2.5/5 mg Tablets Zomig 03/2012 Antimigraine DCP slot confirmed
 
Zolmitriptan 2.5/5 mg Mouth dissolving tablets Zomig 03/2012 Antimigraine DCP slot confirmed
 
Valsartan 40/80/160 mg Filmcoated tablets Diovan 05/2011 Cardiovascular DCP slot confirmed
 
Sildenafil citrate 25/50/100 mg Tablets Viagra 06/2013 CVS: Erectile disfunction  
 
Irbesartan + HCTZ 150+12.5/300+12.5 mg Filmcoated tablets Co-Aprovel 10/2013 Cardiovascular  
 
Escitalopram 5/10/20 mg Tablets Cipralex 05/2014 Antidepressant  
 
Esomeprazole 20/40 mg Enteric coated tablets Inexium 02/2014 Gastro-intestinal DCP slot confirmed
 
Azithromycin 100 mg/5 ml & 200 mg/5 ml Powder for suspension Zithromax Expired Antibacterial  
 
"Valsartan + HCTZ 80+12.5/160+12.5/ 160+25 mg Filmcoated tablets" Co-Diovan 09/2012 Cardiovascular  
 
Levetiracetam 250/500/750/1000 mg Tablets Keppra 05/2010 Anticonvulsant DCP slot confirmed
 
Atorvastatin 10/20/40/80 mg Tablets Lipitor 11/2011 Cholesterol lowering agent DCP slot condirmed
 
Rizatriptan benzoate 5/10 mg Tablets Maxalt 02/2013 Antimigraine  
 
Rizatriptan benzoate ODT 5/10 mg mouth dissolving tablets Maxalt 02/2013 Antimigraine  
 
Linezolid 600 mg Tablets Zyvoxid 01/2016 Antibacterial DCP slot confirmed
 
Olmesartan 10/20/40 mg Tablets Belsar 02/2017 Antihypertensive DCP slot confirmed

 

Further to the products listed above, information regarding the dossiers in development can be obtained upon request.

 

Disclaimer: Products which are subject to patent protection are offered with respect of the prevailing patent laws. No sales or commercialisation, prior to the expiry date of valid patents, is foreseen to countries where patents are in force.

 

Legal Notice: This product list should not be considered as a representation or as an offer to sell.

News

Tender production
Operationally, 2008 respresented a year of strong growth for Jubilant...

Read more>>

Downloads

PPT Presentation
Download PPT
Product portfolio
Jubilant
Axxes Business Park | Guldensporenpark 22, Block C | 9820 Merelbeke | Belgium | Phone: +32 (0)9 233 14 04 | Fax: +32 (0)9 233 00 16 | | Disclaimer